ᱢᱤᱫ ᱥᱟᱫᱷᱟᱨᱚᱱ ᱜᱩᱱ ᱫᱚ ᱦᱩᱭᱩᱜ ᱠᱟᱱᱟ ᱜᱞᱩᱠᱚᱡᱽ ᱨᱮᱭᱟᱜ ᱵᱮᱵᱷᱟᱨ, ᱡᱟᱦᱟᱸ ᱨᱮ ᱜᱞᱩᱠᱚᱡᱽ ᱟᱨ ᱤᱱᱡᱮᱠᱥᱚᱱ ᱨᱮᱭᱟᱜ ᱢᱤᱫ ᱥᱮᱬᱟ ᱦᱤᱥᱟᱹ ᱫᱚ ᱦᱩᱭᱩᱜ ᱠᱟᱱᱟ᱾ Rehydration refers to the process by which gelatin capsules transition from a dry or glassy state back to their original swelling properties and mechanical strength under specific environmental conditions. ᱱᱚᱣᱟ ᱠᱟᱹᱢᱤᱦᱚᱨᱟ ᱫᱚ ᱮᱱᱴᱤᱵᱚᱰᱤᱡᱽ ᱨᱮᱭᱟᱜ ᱢᱤᱫ ᱥᱮᱬᱟ ᱦᱤᱥᱟᱹ ᱠᱟᱱᱟ, ᱡᱟᱦᱟᱸ ᱫᱚ ᱥᱤᱥᱴᱟᱢ ᱨᱮ ᱢᱮᱱᱟᱜ ᱠᱚ ᱞᱟᱹᱜᱤᱫ ᱢᱤᱫ ᱞᱮᱠᱟᱱ ᱠᱟᱹᱢᱤ ᱠᱚ ᱨᱮᱭᱟᱜ ᱫᱟᱲᱮ ᱠᱚ ᱠᱚᱢ ᱫᱟᱲᱮᱭᱟᱜ-ᱟ᱾
ᱦᱚᱲᱢᱚ ᱨᱮᱭᱟᱜ ᱥᱟᱭᱠᱚᱢᱮᱴᱨᱤᱠ ᱜᱩᱱ ᱠᱚ ᱾
α-Code lạgit̕ kạmi lạgit̕ kạmi lạgit̕ lạgit̕ lạgit̕ kạmi lạgit̕ lạgit̕ kạmi lạgit̕ kạmi lạgit̕ kạmi lạgit̕ kạmi lạgit̕ kạmi lạgit̕ lạgit̕ kạmi lạgit̕ kạmi lạgit̕ kạmi lạgit̕ lạgit̕ lạgit̕ lạgit̕ kạmi lạgit̕ lạgit̕ kana. ᱢᱤᱫ ᱠᱮᱴᱮᱡ, ᱦᱟᱭᱰᱨᱚᱡᱮᱱ, ᱮᱞᱩᱢᱤᱱᱟᱢ, ᱟᱨ ᱜᱞᱩᱠᱚᱡᱽ ᱵᱚᱫᱚᱞ ᱠᱟᱛᱮ ᱟᱨᱟᱵᱤᱰ-ᱤᱱᱯᱷᱞᱟᱢᱮᱴᱟᱨᱤ ᱨᱮ ᱵᱚᱫᱚᱞ ᱨᱮᱭᱟᱜ ᱢᱤᱫ ᱢᱟᱨᱟᱝ ᱠᱟᱹᱢᱤ ᱫᱚ ᱦᱩᱭᱩᱜ ᱠᱟᱱᱟ ᱾ Upon contact with water or bodily fluids, water molecules penetrate and disrupt these hydrogen bonds, prompting the molecular chains to unfold and re-form an elastic three-dimensional hydrogel network. ᱱᱚᱶᱟ ᱠᱟᱹᱢᱤ ᱨᱮ, 20% ᱠᱷᱚᱱ ᱵᱟᱹᱲᱛᱤ ᱵᱟᱹᱲᱛᱤ ᱵᱟᱹᱲᱛᱤ ᱵᱟᱹᱲᱛᱤ ᱵᱟᱹᱲᱛᱤ ᱠᱟᱱᱟ, ᱟᱨ (i) ᱫᱚ ᱵᱟᱝ ᱵᱟᱹᱲᱤᱡ ᱟᱨ ᱵᱟᱹᱲᱤᱡ ᱠᱟᱹᱢᱤ ᱠᱚ ᱨᱮᱭᱟᱜ ᱢᱤᱫ ᱫᱷᱟᱯ ᱨᱮ ᱢᱮᱱᱟᱜ-ᱟ, ᱚᱱᱟ ᱫᱚ ᱯᱟᱨᱤᱵᱮᱥ ᱨᱮ ᱵᱟᱝ ᱛᱟᱦᱮᱱ ᱠᱟᱱᱟ᱾
ᱠᱚᱨᱚᱱᱟᱣᱟᱭᱨᱮᱥ ᱨᱤᱥᱟᱭᱠᱞᱤᱝ ᱨᱮᱭᱟᱜ ᱜᱩᱱ ᱠᱚ ᱾
ᱢᱮᱴᱨᱤᱠᱥ 1:15-50 kg apps aptions kạmi lạgit̕ lạgit̕ lạgit̕ lạgit̕ lạgit̕ lạgit̕ lạgit̕ lạgit̕ lạgit̕ lạgit̕ lạgit̕ lạgit̕ lạgit̕, ᱱᱚᱶᱟ ᱫᱚ 1.5 million-ms ᱠᱟᱱᱟ, ᱚᱱᱟ ᱫᱚ 7 ms, rpm , ᱡᱟᱦᱟᱸ ᱨᱮ 6-kg a impositive; second, recovery of mechanical strength-after rehydration, the capsule's fracture strength should be maintained between 1.5-2.5N·mm⁻², sufficient to encapsulate contents and remain intact during transportation; third, synchronized disintegration, the rehydrated capsule wall dissolves uniformly in specific pH environments, preventing localized burst release of the drug and enhancing bioavailability.
ᱯᱷᱟᱨᱢᱟᱥᱭᱩᱴᱤᱠᱟᱞ ᱤᱱᱴᱮᱜᱽᱨᱮᱴᱮᱰ ᱤᱱᱴᱮᱜᱽᱨᱮᱥᱚᱱ ᱾
ᱮᱱᱴᱤᱵᱟᱭᱚᱴᱤᱠ, ᱤᱱᱴᱮᱜᱽᱨᱮᱴᱮᱰ ᱴᱮᱠᱱᱚᱞᱚᱡᱤ ᱨᱮᱭᱟᱜ ᱰᱟᱭᱜᱽᱱᱚᱥᱤᱥ ᱨᱮᱭᱟᱜ ᱮᱴᱠᱮᱴᱚᱬᱮ ᱥᱚᱞᱦᱮᱭ ᱞᱟᱹᱜᱤᱫ ᱾ ᱱᱚᱶᱟ ᱠᱚ ᱢᱩᱫᱽ ᱨᱮ, ᱱᱚᱶᱟ ᱫᱚ ᱜᱞᱩᱠᱚᱡᱽ ᱨᱮ ᱵᱟᱹᱲᱛᱤ ᱠᱟᱹᱢᱤ ᱠᱟᱱᱟ, ᱚᱱᱟ ᱛᱮ ᱜᱞᱩᱠᱚᱡᱽ ᱨᱮ ᱜᱞᱩᱠᱚᱡᱽ ᱟᱨ ᱴᱮᱠᱱᱚᱞᱚᱡᱤ ᱨᱮᱭᱟᱜ ᱠᱟᱹᱢᱤ ᱠᱚ ᱠᱚᱢ ᱞᱟᱹᱜᱤᱫ ᱜᱚᱲᱚ ᱮᱢ ᱫᱟᱲᱮᱭᱟᱜ-ᱟ ᱾ For sustained- and controlled-release formulations, the rehydration rate and the formation speed of the swollen layer jointly determine the drug release profile. ᱱᱚᱶᱟ ᱪᱷᱟᱰᱟ ᱠᱟᱛᱮ 6.5 millions hirancial official firanssion ᱫᱚ 2.5 millions hoption ar hocalized lạgit̕ jạruṛaṛa kạmi lạgit̕, ᱚᱱᱟ ᱫᱚ 60% ᱠᱷᱚᱱ ᱵᱟᱹᱲᱛᱤ ᱵᱟᱹᱲᱛᱤ ᱢᱮᱱᱟᱜ-ᱟ ᱾
ᱦᱟᱭᱵᱨᱤᱰᱟᱭᱡᱮᱥᱚᱱ ᱨᱮᱭᱟᱜ ᱜᱩᱱ ᱠᱚᱤᱞᱮᱠᱴᱨᱳᱰ ᱠᱚ ᱫᱚ ᱠᱷᱟᱹᱞᱤ ᱔ᱦᱚᱲᱢᱚ ᱥᱟᱶᱟᱨ, ᱦᱚᱲᱢᱚ ᱟᱨ ᱵᱮᱵᱷᱟᱨ ᱨᱮᱭᱟᱜ ᱢᱤᱫ ᱢᱩᱲᱩᱫ ᱮᱴᱠᱮᱴᱚᱬᱮ ᱫᱚ ᱦᱩᱭᱩᱜ ᱠᱟᱱᱟ᱾ With advancements in smart excipients, precisely tailoring rehydration behavior by adjusting gelatin sources (eg, the ratio of Type A to Type B gelatin), crosslinking degree, and composite modifications can provide superior carriers for targeted drug delivery, pulsatile release, and other novel formulations-continuously driving innovation in drug delivery systems. ᱡᱩᱫᱤ ᱩᱱᱠᱩ ᱫᱚ ᱥᱤ ᱤ ᱳ ᱠᱚ ᱥᱟᱶ ᱡᱟᱦᱟᱱ ᱮᱴᱠᱮᱴᱚᱬᱮ ᱠᱚ ᱦᱟᱛᱟᱣᱟ, ᱮᱱᱠᱷᱟᱱ ᱥᱤ ᱮᱢ ᱥᱤ ᱨᱮᱭᱟᱜ ᱪᱤᱱᱦᱟᱹ ᱠᱚ ᱞᱟᱹᱜᱤᱫ ᱾
